Skip to search.
 TSX Down 0.53% TSX Ventures Down 0.63%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
3.68 Down 0.12(3.16%) Sep 26, 3:59PM EDT
Prev Close:3.80
Open:3.73
Bid:N/A
Ask:6.45 x 900
1y Target Est:16.00
Beta:1.49951
Earnings Date:Nov 8 - Nov 14 (Est.)
Day's Range:3.67 - 3.75
52wk Range:2.80 - 10.88
Volume:3,982
Avg Vol (3m):45,111
Market Cap:5.60M
P/E (ttm):N/A
EPS (ttm):-11.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHDown 3.16%5.60M
LLYDown 2.02%83.92B
PFEDown 1.81%204.05B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.72
Quarterly EPS Est (Sep-16) :-3.29
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback